These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8932505)

  • 1. Staphylococcal vaccines: a realistic dream.
    Fattom AI; Naso R
    Ann Med; 1996 Feb; 28(1):43-6. PubMed ID: 8932505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide.
    Scully IL; Pavliak V; Timofeyeva Y; Liu Y; Singer C; Anderson AS
    Hum Vaccin Immunother; 2018 Jan; 14(1):81-84. PubMed ID: 29182428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine models of staphylococcal infection.
    Cook J; Hepler R; Pancari G; Kuklin N; Fan H; Wang XM; Cope L; Tan C; Joyce J; Onishi J; Montgomery D; Anderson A; McNeely T
    Hum Vaccin; 2009 Apr; 5(4):254-63. PubMed ID: 18787395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and preclinical evaluation of two novel Staphylococcus aureus capsular polysaccharide 5 and 8-fusion protein (Hla-MntC-SACOL0723) immunoconjugates.
    Ahmadi K; Aslani MM; Pouladfar G; Faezi S; Kalani M; Pourmand MR; Ghaedi T; Havaei SA; Mahdavi M
    IUBMB Life; 2020 Feb; 72(2):226-236. PubMed ID: 31573748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
    Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.
    Fattom AI; Sarwar J; Basham L; Ennifar S; Naso R
    Infect Immun; 1998 Oct; 66(10):4588-92. PubMed ID: 9746554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
    Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
    Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
    Liu B; Park S; Thompson CD; Li X; Lee JC
    Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
    Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.
    Lattar SM; Noto Llana M; Denoël P; Germain S; Buzzola FR; Lee JC; Sordelli DO
    Infect Immun; 2014 Jan; 82(1):83-91. PubMed ID: 24126523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia.
    Roghmann M; Taylor KL; Gupte A; Zhan M; Johnson JA; Cross A; Edelman R; Fattom AI
    J Hosp Infect; 2005 Jan; 59(1):27-32. PubMed ID: 15571850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.
    McKenney D; Pouliot KL; Wang Y; Murthy V; Ulrich M; Döring G; Lee JC; Goldmann DA; Pier GB
    Science; 1999 May; 284(5419):1523-7. PubMed ID: 10348739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?
    Shinefield HR
    Vaccine; 2006 Apr; 24 Suppl 2():S2-65-9. PubMed ID: 16823932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical laboratory evaluation of a bivalent Staphylococcus aureus saccharide-exotoxin A protein conjugate vaccine.
    Ho MM; Bolgiano B; Martino A; Kairo SK; Corbel MJ
    Hum Vaccin; 2006; 2(3):89-98. PubMed ID: 17012902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design.
    Nanra JS; Timofeyeva Y; Buitrago SM; Sellman BR; Dilts DA; Fink P; Nunez L; Hagen M; Matsuka YV; Mininni T; Zhu D; Pavliak V; Green BA; Jansen KU; Anderson AS
    Vaccine; 2009 May; 27(25-26):3276-80. PubMed ID: 19200819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic approaches against Staphylococcus aureus.
    Verkaik NJ; van Wamel WJ; van Belkum A
    Immunotherapy; 2011 Sep; 3(9):1063-73. PubMed ID: 21913829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.
    Wacker M; Wang L; Kowarik M; Dowd M; Lipowsky G; Faridmoayer A; Shields K; Park S; Alaimo C; Kelley KA; Braun M; Quebatte J; Gambillara V; Carranza P; Steffen M; Lee JC
    J Infect Dis; 2014 May; 209(10):1551-61. PubMed ID: 24308931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.
    Robbins JB; Schneerson R; Horwith G; Naso R; Fattom A
    Am Heart J; 2004 Apr; 147(4):593-8. PubMed ID: 15077073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.